Press Releases

A Mighty product gives hope to Asthma sufferers

26-Mar-07

A unique, new product which has been developed in the UK has been launched to help the increasing numbers of people suffering with Asthma and other respiratory allergies. The scientifically and clinically proven Dust Mite Controller is available from Tower Health, a leading provider of innovative health products in the UK. It has been developed to tackle the growing problems caused by the miniscule dust mite.

A unique, new product which has been developed in the UK has been launched to help the increasing numbers of people suffering with Asthma and other respiratory allergies. The scientifically and clinically proven Dust Mite Controller is available from Tower Health, a leading provider of innovative health products in the UK. It has been developed to tackle the growing problems caused by the miniscule dust mite.

It is a staggering fact that 1 in 3 of the UK population are affected by allergies at some point in their lives - many of these directly attributed to the dust mite. In fact 5.2 million of the population are asthma suffers whilst over 15% of the population are thought to suffer hayfever which includes perennial rhinitis. Unlike pollen which is one of the causes of hayfever, dust mites are present all year round causing constant allergy 'perennial' allergic rhinitis.

These symptoms are a major problem for parents, as an increasing number of children are affected by the dust mite. In fact, figures show that 1 in 3 children are in some way allergic to the dust mite allergens. In addition, the dust mite can also be responsible for infantile eczema.

The traditional way to reduce the dust mite has been through hours and hours of hard work - every week. This can involve vacuuming, cleaning, washing and scrubbing which apart from being tedious, time-consuming and dull, still inevitably leaves the mite to thrive.

The Dust Mite Controller couldn't involve less hard work! Simply plug it in and it does everything for you. The Dust Mite Controller is unique in the way it works - there is nothing like it in the World and it has the clinical and scientific evidence to support this. The device emits a range of ultrasonic sounds (not heard by humans or pets) when plugged in. These sounds interfere with the feeding and reproductive cycles of the dust mite, reducing the population of the dust mite and the allergens produced (faecal matter).

Commenting upon the new Dust Mite Controller Roger Bratton, Director at Tower Health said, "The Dust Mite Controller is a unique device which has been developed by a team of experts from the UK. It has been developed to answer the needs of the millions of allergy sufferers in the UK and around the globe who are affected by the tiny enemy - the dust mite. The clinical and scientific evidence demonstrates its effectiveness and already we have testimonials from many satisfied customers."

The Dust Mite Controller is a non toxic device, without any use of chemical substances. Priced at £49.95, the Dust Mite Controller is available from www.tower-health.co.uk or by calling 08450 066 077.

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

Latest News

DoH urged to banish blame culture from NHS

As many as 10% of patients admitted to hospital suffer some form of harm, much of which is avoidable... Read more

'Pay GPs and pharmacists to work together'

Closer working between GPs and community pharmacists could help to save lives and may prove to be mo... Read more

Dispensing practices battle near-repeat pharmacy bid

Dispensing practices in Fife are battling an application to open a new pharmacy, weeks after defeati... Read more

BMA backs partnership incentives for practices

The GPC must negotiate 'new contractual incentives' to encourage practices to take on partners, the ... Read more

GMC sets mid-August licence-to-practise deadline

Doctors who want to go on working in the UK after November must tell the GMC by 14 August. Read more

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more

Jobs

 

Job of the Week